As previously mentioned, our data showed a significant alteration in the A375 human melanoma cells bioenergetic profile after the treatment with Api, especially at the higher tested dose, 60 μM, an effect that might be correlated with its beneficial effects against melanoma. This evidence concerns the gene SERPINF2 and melanoma.